Detalhe da pesquisa
1.
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort.
Gastroenterol Hepatol
; 2024 May 06.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-38710465
2.
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
United European Gastroenterol J
; 8(9): 1056-1066, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32723069
3.
[Infliximab in the treatment of refractory gastroduodenal Crohn's disease]. / Infliximab en el tratamiento de la enfermedad de Crohn gastroduodenal resistente.
Gastroenterol Hepatol
; 37(1): 21-2, 2014 Jan.
Artigo
Espanhol
| MEDLINE | ID: mdl-24029174
4.
Infliximab en el tratamiento de la enfermedad de Crohn gastroduodenal resistente / Infliximab in the treatment of refractory gastroduodenal Crohn's disease
Gastroenterol. hepatol. (Ed. impr.)
; 37(1): 21-22, ene. 2014. ilus
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-118352